Vendor, San Jose, CA
CCS Associates, Inc.
UEI VCNRS52G5PG7, CAGE 3H9A1
24 awards and $14,455,955 obligated between January 23, 2024 and September 17, 2026, 46% under full and open competition, against 4.9 offers on average where reported.
Sells to
Awarding agencies by dollars.
| National Institutes of Health | $14,455,955 |
| Food and Drug Administration | $0 |
Industries
NAICS on the awards, by dollars.
| Other Scientific and Technical Consulting ServicesNAICS 541690 | $14,457,206 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $40,676 |
| Professional, Scientific, and Technical ServicesNAICS 541712 | -$10,521 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$31,406 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 11 |
| Full and Open Competition | 7 |
| Competed Under SAP | 6 |
| Small Business Set Aside - Total | 13 |
| Delivery Order | 9 |
| Definitive Contract | 8 |
| Purchase Order | 4 |
Hear when CCS Associates, Inc. wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
Contracts CCS Associates, Inc. holds whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 3
- Obligated so far
- $720,857
- Soonest
- March 13, 2027
The 3 contracts, the office behind each one and the dates are in the workspace. See them
Competes with
Vendors selling other scientific and technical consulting services to National Institutes of Health, by dollars.
| Kelly Services, Inc.Troy, MI | $367,542,134 |
| Gap Solutions, Inc.Herndon, VA | $269,925,480 |
| Dataconsult-Io LLCGlen Echo, MD | $17,703,468 |
| Digitalis Commons, Inc.New York, NY | $12,853,836 |
| Systex, Inc.Rockville, MD | $11,189,290 |
| Lab2market, PBCDana Point, CA | $4,983,365 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91023C00054Definitive Contract, August 7, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | The Purpose of This Requirement Is to Provide Regulatory Services and Technical Support to the Division of Cancer Prevention (Dcp) at the NaNAICS 541690, PSC R499 | $9,437,240 |
| 75N91023C00055Definitive Contract, September 10, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | NIH NCINational Institutes of Health | The Purpose of the Acquisition Is to Provide a Variety of Critical Cancer Prevention Information Management Functions Necessary to Support tNAICS 541690, PSC R499 | $3,751,484 |
| 75N95025F00001Delivery Order, March 28, 2025, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Preparation, Review, and Submission for Clinical Trials Associated with Nida Drug Supply Program. N01DA-23-8933. April 1, 2025 toNAICS 541690, PSC B528 | $394,539 |
| 75N95026F00001Delivery Order, March 25, 2026, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Preparation, Review, and Submission for Clinical Trials Associated with Nida Drug Supply Program. N01DA-23-8933. March 27, 2026 tNAICS 541690, PSC B528 | $335,910 |
| 75N95024F00001Delivery Order, March 27, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. April 1, 2024 to March 31, 2025NAICS 541690, PSC R699 | $307,737 |
| 75N95023P00808Purchase Order, January 23, 2024, Competed Under SAP, 13 offers | National Institutes of Health NidaNational Institutes of Health | Regulatory Affairs Consulting Support ServicesNAICS 541990, PSC R499 | $271,701 |
| 75N95025F00001Delivery Order, May 20, 2025, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | New Sow for Regulatory Activities for Pcca and Mmab Gene Therapy ProductsNAICS 541690, PSC R499 | $230,617 |
| 75N98026F00001Delivery Order, August 27, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health OlaoNational Institutes of Health | Regulatory Support for Lead Gene Therapy Candidates as a Treatment for Congenital Myasthenic SyndromesNAICS 541690, PSC R499 | $159,116 |
| 75N95023P00692Purchase Order, March 14, 2024, Competed Under SAP, 8 offers | National Institutes of Health NidaNational Institutes of Health | Medical Writing Consulting ServicesNAICS 541690, PSC R499 | $154,331 |
| 75F40121C00165Definitive Contract, July 15, 2025, Competed Under SAP, 2 offers | FDA Office of Acq Grant SVCSFood and Drug Administration | The Contractor Shall Provide the Following Tasks/Deliverables Over the Course of the Contract.NAICS 541690, PSC Q999 | $0 |
| 75N93021D00040March 11, 2026, Full and Open Competition, 29 offers | National Institutes of Health NiaidNational Institutes of Health | The Purpose of This Modification Is to Revise Section J. List of Attachments, Item 1. Statement of Work. the Revision Removes Language LimitNAICS 541714, PSC AN42 | $0 |
| 75N95022D00013August 27, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | EO14398 Cro Support for Ncats Regulatory Affairs Support and Related ServicesNAICS 541690, PSC R499 | $0 |
| 75N95023D00025July 28, 2026, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. September 20, 2023 to September 19, 2028.NAICS 541690, PSC R699 | $0 |
| 75N95022F00002Delivery Order, May 28, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Regulatory Support for Preparation and Filing of a Pre-Investigational New Drug (Pre-Ind) Application with the Food and NAICS 541690, PSC R499 | -$281 |
| 75N95022F00001Delivery Order, May 28, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Preparation of an Investigational New Drug (Ind) Application with Food and Drug Administration (Fda) for a Treatment forNAICS 541690, PSC R499 | -$1,457 |
| 75N93021F00001Delivery Order, September 17, 2026, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541714, PSC AN42 | -$2,000 |
| HHSN268201400001CDefinitive Contract, September 26, 2024, Full and Open Competition After Exclusion of Sources, 1 offers | National Institutes of Health NhlbiNational Institutes of Health | Vita 2 - Administrative Coordinating CenterNAICS 541712, PSC AN12 | -$10,521 |
| 75N95020P00601Purchase Order, September 15, 2026, Competed Under SAP, 4 offers | National Institutes of Health NidaNational Institutes of Health | To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation fNAICS 541990, PSC R499 | -$14,184 |
| HHSN271201500084CDefinitive Contract, August 5, 2024, Competed Under SAP, 3 offers | National Institutes of Health NidaNational Institutes of Health | Ninds BPN Medical Writing ConsultantNAICS 541690, PSC R499 | -$19,175 |
| 75N95020P00589Purchase Order, June 2, 2026, Competed Under SAP, 5 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Medical Writing Consulting and Drug Dossier Development Support ServicesNAICS 541990, PSC R499 | -$22,255 |
| 75N93024F00001Delivery Order, March 31, 2025, Full and Open Competition | National Institutes of Health NiaidNational Institutes of Health | To De-Obligate Remaining Funds and Administratively Close the Task Order.NAICS 541714, PSC AN42 | -$29,406 |
| 75N91018C00030Definitive Contract, June 14, 2024, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | Technical Information Research for Cancer Preventive Agent Development. Period of Performance: 09/30/2022 - 09/29/2023NAICS 541690, PSC R499 | -$57,735 |
| HHSN271201700070CDefinitive Contract, May 14, 2024, Full and Open Competition After Exclusion of Sources, 4 offers | National Institutes of Health NidaNational Institutes of Health | Regulatory Affairs SupportNAICS 541990, PSC AN16 | -$194,586 |
| 75N91018C00017Definitive Contract, May 22, 2024, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Regulatory Support for Cancer Prevention Agent DevelopmentNAICS 541690, PSC R499 | -$235,119 |
- Places of performance
- CaliforniaMaryland
- Product and service codes
- R499 Other Professional ServicesB528 Regulatory StudiesR699 Other Administrative Support ServicesQ999 Other Medical ServicesAN12 Health R&D Services; Health Care Services; Applied ResearchAN42 Health R&D Services; Health Care - Other; Applied Research
- Transactions
- 60 across 24 awards